Search
for
Sort by
Research 301–330 of 1000+
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Unraveling the Therapeutic Potential of Miracle Plant ‘Aftimoon’ in Disease Prevention and Treatment: A Comprehensive Review
- A Novel Nomogram for Predicting Gonadotropin-Releasing Hormone Analogue Treatment Outcome in Girls with Idiopathic Central Precocious Puberty
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Exploring Nanotechnology With Traditional Herbal Pharmacology: Nano Carrier-Based Phytochemical Delivery In PCOS Treatment
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis
- A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- INFLUENCE OF THE TYPE AND STYLE OF FEVER, SMOKING STATUS, DEGREE OF ANDROGENETIC ALOPECIA ON THE PHASES OF HAIR GROWTH IN MILITARY SERVICEMEN UNDER INPATIENT TREATMENT WITH A DIAGNOSIS OF PNEUMONIA
- Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism
- Genome-wide shifts in gene expression induced in theca-interstitial cells by inflammatory stimuli
- The influence of androgens on insulin resistance
- Current evaluation of amenorrhea
- New Therapeutic Approach to the Hirsute Patient
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Gender-Affirming Hormone Therapy for Transgender Men
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- Testosterone (T) secreting tumor or insulin resistance? metformin (M) as a diagnostic (Dx) and therapeutic (Rx) trial
- The perception of donor gametes from male and female members of infertile couples
- CONSULTING “DR. GOOGLE” FOR FINASTERIDE SEXUAL SIDE EFFECTS: A CONTEMPORARY WORLDWIDE TRENDS ANALYSIS
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome